Stem Cell Bio-Medical Company, StemLife Berhad To List on Bursa Malaysia Securities Berhad

Malaysia’s leading bio-medical company in the stem cell industry, StemLife Berhad (StemLife), en-route to list on the MESDAQ Market of Bursa Malaysia Securities Berhad launched its prospectus today and revealed its plans to invest up to RM8.1 million for expansion of the company’s branches and existing laboratories as well as the set up of a new third laboratory, as part of its utilisation of proceeds from its Initial Public Offering (IPO). StemLife’s list of achievements include not only being the first company in Malaysia to offer stem cell banking in both Umbilical Cord Blood Stem Cell (UCBSC) and Peripheral Blood Stem Cell (PBSC), normally referred to as cord blood banking and adult stem cell banking respectively, but also the first company to offer stem cell therapeutic advisory services in the Asia Pacific region. The company deals with enhancing the quality of life with stem cells, hence the company’s name, StemLife. (PRWeb Sep 30, 2006)


Trackback URI: http://www.prweb.com/zingpr.php/TG92ZS1QaWdnLUxvdmUtU3VtbS1JbnNlLVplcm8=



[Please register to see this link Register]